BIOMAT Database Logo BIOMAT Database Logo

Sulfasalazine-induced fulminant hepatic failure. 1992

G Marinos, and J Riley, and D M Painter, and G W McCaughan
A.W. Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Camperdown, Australia.

We report two cases of massive hepatic necrosis associated with sulfasalazine. Both patients had underlying inflammatory bowel disease. One of the patients had a history of an ill-defined autoimmune disorder (Sjögren's syndrome). Symptoms and signs of a generalized hypersensitivity reaction were present in both patients. One patient died of a subarachnoid hemorrhage while awaiting transplant, the second died 2 weeks after transplant from disseminated aspergillosis. These two cases remind us of one of the potential hazards of sulfasalazine at a time when alternative therapies are now available.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003093 Colitis, Ulcerative Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN. Colitis Gravis,Idiopathic Proctocolitis,Inflammatory Bowel Disease, Ulcerative Colitis Type,Ulcerative Colitis
D005260 Female Females
D006501 Hepatic Encephalopathy A syndrome characterized by central nervous system dysfunction in association with LIVER FAILURE, including portal-systemic shunts. Clinical features include lethargy and CONFUSION (frequently progressing to COMA); ASTERIXIS; NYSTAGMUS, PATHOLOGIC; brisk oculovestibular reflexes; decorticate and decerebrate posturing; MUSCLE SPASTICITY; and bilateral extensor plantar reflexes (see REFLEX, BABINSKI). ELECTROENCEPHALOGRAPHY may demonstrate triphasic waves. (From Adams et al., Principles of Neurology, 6th ed, pp1117-20; Plum & Posner, Diagnosis of Stupor and Coma, 3rd ed, p222-5) Encephalopathy, Hepatic,Portosystemic Encephalopathy,Encephalopathy, Hepatocerebral,Encephalopathy, Portal-Systemic,Encephalopathy, Portosystemic,Fulminant Hepatic Failure with Cerebral Edema,Hepatic Coma,Hepatic Stupor,Hepatocerebral Encephalopathy,Portal-Systemic Encephalopathy,Coma, Hepatic,Comas, Hepatic,Encephalopathies, Hepatic,Encephalopathies, Hepatocerebral,Encephalopathies, Portal-Systemic,Encephalopathies, Portosystemic,Encephalopathy, Portal Systemic,Hepatic Comas,Hepatic Encephalopathies,Hepatic Stupors,Hepatocerebral Encephalopathies,Portal Systemic Encephalopathy,Portal-Systemic Encephalopathies,Portosystemic Encephalopathies,Stupor, Hepatic,Stupors, Hepatic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012460 Sulfasalazine A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907) Salicylazosulfapyridine,Asulfidine,Azulfadine,Azulfidine,Azulfidine EN,Colo-Pleon,Pleon,Pyralin EN,Salazopyrin,Salazosulfapyridine,Sulfasalazin medac,Sulfasalazin-Heyl,Sulfasalazine FNA,Sulphasalazine,Ucine,Ulcol,ratio-Sulfasalazine,Colo Pleon,Sulfasalazin Heyl,ratio Sulfasalazine
D012859 Sjogren's Syndrome Chronic inflammatory and autoimmune disease in which the salivary and lacrimal glands undergo progressive destruction by lymphocytes and plasma cells resulting in decreased production of saliva and tears. The primary form, often called sicca syndrome, involves both KERATOCONJUNCTIVITIS SICCA and XEROSTOMIA. The secondary form includes, in addition, the presence of a connective tissue disease, usually rheumatoid arthritis. Sicca Syndrome,Sjogren Syndrome,Sjogrens Syndrome,Syndrome, Sicca,Syndrome, Sjogren's

Related Publications

G Marinos, and J Riley, and D M Painter, and G W McCaughan
Sulfasalazine-induced fulminant hepatic failure and necrotizing pancreatitis.
May 1994, The American journal of gastroenterology,
G Marinos, and J Riley, and D M Painter, and G W McCaughan
Halothane-induced fulminant hepatic failure.
July 1993, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology,
G Marinos, and J Riley, and D M Painter, and G W McCaughan
Kava-induced fulminant hepatic failure.
June 2002, Journal of the American Academy of Child and Adolescent Psychiatry,
G Marinos, and J Riley, and D M Painter, and G W McCaughan
Phenelzine-induced fulminant hepatic failure.
April 1996, Annals of internal medicine,
G Marinos, and J Riley, and D M Painter, and G W McCaughan
Galactosamine-induced fulminant hepatic failure.
November 1997, Hepatology (Baltimore, Md.),
G Marinos, and J Riley, and D M Painter, and G W McCaughan
Halothane induced fulminant hepatic failure.
February 2007, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP,
G Marinos, and J Riley, and D M Painter, and G W McCaughan
Vicodin-induced fulminant hepatic failure.
October 1993, Anesthesiology,
G Marinos, and J Riley, and D M Painter, and G W McCaughan
Nortriptyline-induced fulminant hepatic failure.
January 1995, Journal of clinical gastroenterology,
G Marinos, and J Riley, and D M Painter, and G W McCaughan
Orlistat-induced fulminant hepatic failure.
December 2014, Clinical obesity,
G Marinos, and J Riley, and D M Painter, and G W McCaughan
Thalidomide-induced fulminant hepatic failure.
May 2007, Mayo Clinic proceedings,
Copied contents to your clipboard!